Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-29
2006-08-29
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252140
Reexamination Certificate
active
07098214
ABSTRACT:
Dopamine D3receptor ligands or antagonists are disclosed for use in the treatment of renal function disorders, such as diabetic nephropathy.
REFERENCES:
Luippold et al., Naunyn-Schmiedeberg's Arch. Pharmacol., 358 (6), 690-3 (Dec., 1998).
Gross Gerhard
Mühlbauer Bernd
Starck Dorothea
Treiber Hans-Jörg
Abbott & GmbH & Co. KG
Novak Druce DeLuca & Quigg
Spivack Phyllis G.
LandOfFree
Dopamine D 3 receptor ligands or antagonists for use in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dopamine D 3 receptor ligands or antagonists for use in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine D 3 receptor ligands or antagonists for use in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3633990